CVI Investments, Inc. 13D and 13G filings for BriaCell Therapeutics Corp.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 12:17 pm Sale | 2024-09-30 | 13G | BriaCell Therapeutics Corp. BCTX | CVI Investments, Inc. | 40,000 1.900% | -133,913 (-77.00%) | Filing |
| 2024-09-16 10:22 am Purchase | 2024-09-11 | 13G | BriaCell Therapeutics Corp. BCTX | CVI Investments, Inc. | 173,913 8.500% | 173,913 (New Position) | Filing |